StockData
Acrivon Therapeutics, Inc. logo

Acrivon Therapeutics, Inc. (ACRV) stock

ACRVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.43−0.03 (-2.05%)

Close on Nov 17, 2026Market cap $61.28MP/E –Yield –

How the market prices Acrivon Therapeutics

Each ratio against its own distribution since 2022, from month-end prices and the figures reported at the time

Acrivon Therapeutics trades at 0.7× its earnings, against a median of 0.9× since 2022 — on the cheap side of its own range.

The shaded bar covers the 5th to 95th percentile of month-end values since 2022, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to book since 2022

Median 0.9×, today 0.7×

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity-64.6%vs -53.5%
Return on assets-57.6%vs -40.7%
Return on invested capital-5337.5%vs -32.4%
Return on capital employed-89.4%vs -38.7%

How hard the assets work

Profit per employee-$1.00Mvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $89.96M.

Cash and short-term investments$89.96M
EBITDA, trailing twelve months-$78.37M
Free cash flow, trailing twelve months-$64.14M

Leverage and liquidity

Current ratio7.99vs 3.28
Quick ratio7.86vs 2.37

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

-3.09
DistressGrey zoneSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

2 of 9 tests passed

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield-121.1%vs -22.8%
Free cash flow yield-104.7%vs -9.68%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 17, 2026

$1.2752-week low52-week high$3.56
$1.4320-day200-day50-day

The close sits 7% of the way up the 52-week range, 59.8% below the high.

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

32
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

ACRVS&P 500
PeriodACRVS&P 500DifferenceACRV per yearS&P 500 per year
1 month-12.8%-4.0%−8.8 pts
3 months-30.2%-5.0%−25.3 pts
Year to date-40.7%+8.2%−48.9 pts
1 year-39.9%+11.2%−51.1 pts
3 years-63.2%+68.5%−131.7 pts-28.4%+19.0%

How much it moves

Volatility, 1 year85.8%vs 80.5%
Volume against its 90-day average1.38vs 0.86

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

2M ACRV shares were sold short on Oct 30, 2026, up 3.9% from the previous report, or 10.79% of the shares available to trade. At recent volumes it would take 11.4 days to buy them back. Over the last 20 sessions, 56.6% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Short interest as a share of the float10.8%vs 8.89%
Short interest as a share of all shares4.21%vs 6.30%
Days of volume to buy it back11.37vs 5.13

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20261,804,674+3.9%158,68111.4
Oct 15, 20261,737,689+7.5%264,5386.6
Sep 30, 20261,616,727+34.4%367,4694.4
Sep 15, 20261,202,619+5.6%243,6024.9
Aug 31, 20261,139,237-7.8%409,7412.8
Aug 14, 20261,235,893-8.8%305,4734.0
Jul 31, 20261,355,015-8.9%315,0554.3
Jul 15, 20261,487,445-47.6%636,3792.3
Jun 30, 20262,840,348+0.5%374,4937.6
Jun 15, 20262,827,334+0.9%346,4618.2
May 29, 20262,801,992+12.3%461,2476.1
May 15, 20262,496,168+1.3%563,2114.4

Every measure, in full

61 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Q3 FY2026, expected soon
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 17, 2026

Valuation ratiosIndustry

Market Cap
$61.28M
$254.69M
Enterprise Value
-$28.68M
$130.88M
PB Ratio
0.71
1.99
P/TBV Ratio
0.71
2.23

Share statisticsIndustry

Shares Change (YoY)
3.00%
11.0%
Shares Change (QoQ)
10.6%
0.57%
Float
17M
49M
Shares Held by Insiders
61.0%
11.3%
Shares Held by Institutions
49.9%
56.3%

Short sellingIndustry

Short Interest
2M
–
Short Interest Change
3.85%
-0.80%
Short % of Float
10.8%
8.89%
Short % of Shares Outstanding
4.21%
6.30%
Days to Cover
11.37
5.13

Stock price statisticsIndustry

52-Week High
$3.56
–
52-Week Low
$1.27
–
20-Day Moving Average
$1.64
–
50-Day Moving Average
$1.80
–
200-Day Moving Average
$1.75
–
Average True Range (14)
$0.13
–
Price Change (1 Week)
-8.92%
-7.83%
Price Change (1 Month)
-15.4%
-6.48%
Price Change (3 Months)
-40.2%
-26.6%
Price Change (6 Months)
-10.6%
-22.2%
Price Change (YTD)
-40.7%
-25.6%
Price Change (1 Year)
-36.2%
-23.8%
Price Change (3 Years)
-63.2%
-32.9%
Average Volume (10 Days)
264,477
–
Average Volume (20 Days)
210,088
–
Average Volume (90 Days)
303,183
–
Relative Volume
1.38
0.86
Relative Strength Index (14)
32.3
40.3
Volatility (1 Year)
85.8%
80.5%

Returns on capitalIndustry

Return on Equity (ROE)
-64.6%
-53.5%
Return on Assets (ROA)
-57.6%
-40.7%
Return on Invested Capital (ROIC)
-5337.5%
-32.4%
Return on Capital Employed (ROCE)
-89.4%
-38.7%

Financial positionIndustry

Current Ratio
7.99
3.28
Quick Ratio
7.86
2.37

EfficiencyIndustry

Profits Per Employee
-$1.00M
-$704.12K
Employee Count
74
75

Income statement (TTM)Industry

Operating Income
-$78.37M
-$21.49M
Net Income
-$74.23M
-$22.47M
EBITDA
-$78.37M
-$17.14M
EPS (Diluted)
-$1.88
-$0.83

Balance sheetIndustry

Net Cash (Debt)
$89.96M
$15.31M
Net Cash Per Share
$2.10
$0.72
Equity (Book Value)
$86.67M
$49.40M
Book Value Per Share
$2.02
$1.45
Tangible Book Value
$86.67M
$23.58M
Working Capital
$80.05M
$74.34M

Cash flow (TTM)Industry

Operating Cash Flow
-$62.92M
-$12.17M
Capital Expenditures
-$1.22M
-$1.02M
Free Cash Flow
-$64.14M
-$20.44M
FCF Per Share
-$1.50
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-121.1%
-22.8%
FCF Yield
-104.7%
-9.68%

Scores and fair valueIndustry

Altman Z-Score
-3.09
0.12
Piotroski F-Score
2
4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?